Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study - Top-Institutions - MDSpire

Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study

  • By

  • Zuhir Bodalal

  • Francisco Javier Mendoza Ferradás

  • Olga Maxouri

  • Roberto Iezzi

  • Aleksandar Gjoreski

  • Stavros Spiliopoulos

  • Zoltan Bansaghi

  • Belarmino Gonçalves

  • Bleranda Zeka

  • Nathalie Kaufmann

  • Julien Taieb

  • Regina Beets-Tan

  • Philippe L. Pereira

  • Fernando Gómez Muñoz

  • April 29, 2026

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Interventional Oncology
    • Hepatic Oncology
    • Radiology
    • Medical Imaging Informatics

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Interventional Radiology
    • Oncology
    • Radiomics
    • Hepatobiliary Surgery

  • #3

    European Institute of Oncology (IEO)
    European Institute of Oncology (IEO)

    Milan, Lombardy

    Key Differentiators

    • Interventional Oncology
    • Radiomics
    • Gastrointestinal Oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Interventional Radiology
    • Oncology
    • Radiomics
    • Medical Imaging

Original Source(s)

Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study

  • by Zuhir Bodalal, Francisco Javier Mendoza Ferradás, Olga Maxouri, Roberto Iezzi, Aleksandar Gjoreski, Stavros Spiliopoulos, Zoltan Bansaghi, Belarmino Gonçalves, Bleranda Zeka, Nathalie Kaufmann, Julien Taieb, Regina Beets-Tan, Philippe L. Pereira, Fernando Gómez Muñoz

  • April 29, 2026

Related Content

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

Deep multimodal fusion of patho-radiomic and clinical data for enhanced survival prediction for colorectal cancer patients

Effects of low anterior resection syndrome after colorectal cancer resections on health-related quality of life: a systematic review and meta-analysis